Angioimmunoblastic T-Cell Lymphoma: Long-term Survivorship

Once treatment is completed and AITL is in remission, physicians will continue to monitor the health and status of each patient during follow-up care. Patients in remission should have regular visits with a physician who is familiar with their medical history and the treatments they have received.

Some treatments can cause long-term effects or late effects, which can vary based on duration and frequency of treatments, age, gender and the overall health of each patient at the time of treatment. A physician will check for these effects during follow-up care. Visits may become less frequent the longer the disease remains in remission.

To learn more, see the Lymphoma Survivorship Fact Sheet Series